⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL430949 | 0.81 | — | — | |
| SCHEMBL419805 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL1289421 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL8319543 | 0.77 | — | — | |
| SCHEMBL14899281 | 0.74 | — | — | |
| SCHEMBL292853 | 0.73 | — | — | |
| SCHEMBL431029 | 0.73 | — | — | |
| SCHEMBL15471708 | 0.72 | — | — | |
| SCHEMBL7737993 | 0.72 | — | — | |
| SCHEMBL9939446 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115651043-A | Preparation method of anthracycline derivative | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-110684043-B | C-N axis chiral arylamine compound and preparation method thereof | 温州大学 | 2022-09-06 | — | — | CN | claimed |
| CN-110684043-A | C-N axis chiral arylamine compound and preparation method thereof | 温州大学 | 2020-01-14 | — | — | CN | claimed |
| US-7022860-B2 | Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-04-04 | — | — | US | claimed |
| EP-0650484-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-01-26 | — | — | EP | claimed |
| JP-3106894-A | — | — | None | — | — | JP | disclosed |
| US-20240228502-A1 | 2-PHENYLAMINO PYRROLOPYRIMIDINES AS ACK1 INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-07-11 | — | — | US | disclosed |
| EP-3394197-B1 | METHOD FOR PRODUCING COLORLESS AND AGING-RESISTANT, POLYACRYLATE-BASED PRESSURE-SENSITIVE ADHESIVE COMPOUNDS | TESA SE (DE) | 2024-06-12 | — | — | EP | disclosed |
| US-20240182622-A1 | BLOCK COPOLYMERS, MEMBRANES, AND METHODS | The Florida State University Research Foundation, Inc. | 2024-06-06 | — | — | US | disclosed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |
| US-5191072-A | Drugs, antitumor | JAPAN TOBACCO INC. (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0515232-A1 | 2-benzocoumarinyl-carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| EP-0515217-A1 | 2-Benzocoumarinyl carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| US-5104982-A | ROUTE TO GLYCALS IN THE ALLAL AND GULAL SERIES | YALE UNIVERSITY (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0448412-A2 | A route to glycals in the allal and gulal series | YALE UNIVERSITY (US) | 1991-09-25 | — | — | EP | disclosed |
| EP-0444208-A1 | LIPID A MONOSACCHARIDE ANALOG | Japan Tobacco Inc. (JP) | 1991-09-04 | — | — | EP | disclosed |
| JP-H03106894-A | LIPID A MONOSACCHARIDE ANALOG | JAPAN TOBACCO INC | 1991-05-07 | — | — | JP | disclosed |